Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 925

1.

c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma.

Kiyono K, Suzuki HI, Morishita Y, Komuro A, Iwata C, Yashiro M, Hirakawa K, Kano MR, Miyazono K.

Cancer Sci. 2009 Oct;100(10):1809-16. doi: 10.1111/j.1349-7006.2009.01248.x. Epub 2009 Jun 17.

2.

Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.

Komuro A, Yashiro M, Iwata C, Morishita Y, Johansson E, Matsumoto Y, Watanabe A, Aburatani H, Miyoshi H, Kiyono K, Shirai YT, Suzuki HI, Hirakawa K, Kano MR, Miyazono K.

J Natl Cancer Inst. 2009 Apr 15;101(8):592-604. doi: 10.1093/jnci/djp058. Epub 2009 Apr 7.

3.

Exogenous introduction of tissue inhibitor of metalloproteinase 2 reduces accelerated growth of TGF-β-disrupted diffuse-type gastric carcinoma.

Johansson E, Komuro A, Iwata C, Hagiwara A, Fuse Y, Watanabe A, Morishita Y, Aburatani H, Funa K, Kano MR, Miyazono K.

Cancer Sci. 2010 Nov;101(11):2398-403. doi: 10.1111/j.1349-7006.2010.01688.x.

4.

SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells.

Takahata M, Inoue Y, Tsuda H, Imoto I, Koinuma D, Hayashi M, Ichikura T, Yamori T, Nagasaki K, Yoshida M, Matsuoka M, Morishita K, Yuki K, Hanyu A, Miyazawa K, Inazawa J, Miyazono K, Imamura T.

J Biol Chem. 2009 Jan 30;284(5):3334-44. doi: 10.1074/jbc.M808989200. Epub 2008 Dec 1.

5.

Expression of thrombospondin-1 and Ski are prognostic factors in advanced gastric cancer.

Nakao T, Kurita N, Komatsu M, Yoshikawa K, Iwata T, Utsunomiya T, Shimada M.

Int J Clin Oncol. 2011 Apr;16(2):145-52. doi: 10.1007/s10147-010-0147-5. Epub 2010 Nov 25.

PMID:
21107877
6.

Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.

Azuma H, Ehata S, Miyazaki H, Watabe T, Maruyama O, Imamura T, Sakamoto T, Kiyama S, Kiyama Y, Ubai T, Inamoto T, Takahara S, Itoh Y, Otsuki Y, Katsuoka Y, Miyazono K, Horie S.

J Natl Cancer Inst. 2005 Dec 7;97(23):1734-46.

7.

Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function.

Wang P, Chen Z, Meng ZQ, Fan J, Luo JM, Liang W, Lin JH, Zhou ZH, Chen H, Wang K, Shen YH, Xu ZD, Liu LM.

Carcinogenesis. 2009 Sep;30(9):1497-506. doi: 10.1093/carcin/bgp154. Epub 2009 Jun 22.

9.
10.
11.

Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.

Kodama M, Kitadai Y, Tanaka M, Kuwai T, Tanaka S, Oue N, Yasui W, Chayama K.

Clin Cancer Res. 2008 Nov 15;14(22):7205-14. doi: 10.1158/1078-0432.CCR-08-0818.

12.

Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats.

Marquez-Aguirre A, Sandoval-Rodriguez A, Gonzalez-Cuevas J, Bueno-Topete M, Navarro-Partida J, Arellano-Olivera I, Lucano-Landeros S, Armendariz-Borunda J.

J Gene Med. 2009 Mar;11(3):207-19. doi: 10.1002/jgm.1303.

PMID:
19189315
13.

Involvement of the c-Ski oncoprotein in cell cycle arrest and transformation during nurse cell formation after Trichinella spiralis infection.

Wu Z, Nagano I, Boonmars T, Takahashi Y.

Int J Parasitol. 2006 Sep;36(10-11):1159-66. Epub 2006 Jun 21.

PMID:
16890942
14.

The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor.

Ferrand N, Atfi A, Prunier C.

Cancer Res. 2010 Nov 1;70(21):8457-66. doi: 10.1158/0008-5472.CAN-09-4088. Epub 2010 Oct 19.

15.

Halofuginone inhibits tumor growth in the polyoma middle T antigen mouse via a thrombospondin-1 independent mechanism.

Yee KO, Connolly CM, Pines M, Lawler J.

Cancer Biol Ther. 2006 Feb;5(2):218-24. Epub 2006 Feb 19.

PMID:
16418571
16.

Smad4 expression in gastric adenoma and adenocarcinoma: frequent loss of expression in diffuse type of gastric adenocarcinoma.

Kim JY, Park DY, Kim GH, Choi KU, Lee CH, Huh GY, Sol MY, Song GA, Jeon TY, Kim DH, Sim MS.

Histol Histopathol. 2005 Apr;20(2):543-9.

PMID:
15736060
17.

Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines.

Hu W, Wu W, Nash MA, Freedman RS, Kavanagh JJ, Verschraegen CF.

Anticancer Res. 2000 Mar-Apr;20(2A):729-33.

PMID:
10810347
18.

Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.

Báez A, Cantor A, Fonseca S, Marcos-Martinez M, Mathews LA, Muro-Cacho CA, Muñoz-Antonia T.

Clin Cancer Res. 2005 May 1;11(9):3191-7.

19.

Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.

Ganapathy V, Ge R, Grazioli A, Xie W, Banach-Petrosky W, Kang Y, Lonning S, McPherson J, Yingling JM, Biswas S, Mundy GR, Reiss M.

Mol Cancer. 2010 May 26;9:122. doi: 10.1186/1476-4598-9-122.

20.

Fussel-15, a novel Ski/Sno homolog protein, antagonizes BMP signaling.

Arndt S, Poser I, Moser M, Bosserhoff AK.

Mol Cell Neurosci. 2007 Apr;34(4):603-11. Epub 2007 Jan 11.

PMID:
17292623
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk